510(k) Report

FDA product code · Immunology

Enzyme Immunoassay, Antiparietal Cell Antibody, Antigen, Control

MLEClass II21 CFR 866.5110510(k) required3 decisions since 19950 recalls

3 FDA decisions since 1995. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, immunology panel

Twenty years of MLE at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · MLE

FDA has decided no MLE device since 2007.

Median 510(k) review, days · MLE

Too few MLE 510(k)s in any year since 2007 to give a median.

Recalls per year · MLE

No recall names MLE since 2007.

Adverse event reports per year · MLE

No MAUDE report names MLE since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
FIG. 1 — MLE by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in MLE? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 866.5110.